Domain Associates
Venture capital · San Diego, California, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
16Deep-tech portfolio3 active
11Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Fractyl Health
15Co-investorsShare a portfolio company
Portfolio companies’ first raises and first grants, by year
First raisesFirst federal grants
The year each portfolio company first filed a Form D, and first won a federal grant. These describe the companies, not when this investor joined them.
Portfolio · 16 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| WindMIL Therapeutics | Biotech | Active | Feb 5, 2021 | $44.9M |
| Exelixis | Biotech | Active | Jul 16, 2009 | $3.0M |
| Volcano Corporation | Medtech | Active | — | — |
| Fractyl Health | Medtech | Public | Jan 25, 2022 | $274.5M |
| Sera Prognostics | Medtech | Public | May 11, 2021 | $149.6M |
| NeuroPace | Medtech | Public | Aug 31, 2020 | $186.6M |
| Aldeyra Therapeutics | Biotech | Public | Feb 11, 2019 | $24.6M |
| Syndax Pharmaceuticals | Biotech | Public | Aug 28, 2015 | $139.5M |
| Veracyte | Medtech | Public | Sep 30, 2014 | $22.1M |
| Clovis Oncology | Biotech | Closed | Nov 27, 2013 | $504.6M |
| Glaukos Corporation | Medtech | Public | Jan 25, 2013 | $76.0M |
| Tandem Diabetes Care | Medtech | Public | Sep 11, 2012 | $69.8M |
| Otonomy | Biotech | Closed | Jun 2, 2011 | $20.6M |
| Align Technology | Medtech | Public | Aug 31, 2009 | $72.3M |
| Atara Biotherapeutics | Biotech | Public | — | — |
| ProteinSimple | Medtech | Acquired | — | — |
Peer ranks
Portfolio size#24
Portfolio exits#8
Raises, 12 months#88
Co-investors#133
Co-investors
- Delphi VenturesVenture capital4 shared
- AbbottVenture capital1 shared
- Atlas VentureVenture capital1 shared
- Bessemer Venture PartnersVenture capital1 shared
- Bio-TechneVenture capital1 shared
- Charter Life SciencesVenture capital1 shared
- Foresite CapitalVenture capital1 shared
- F-Prime CapitalVenture capital1 shared
- General CatalystVenture capital1 shared
- IncyteVenture capital1 shared
Sectors
- Medtech9
- Biotech7
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.